Fairmount Assists Agilux in Deal with Charles River Labs

WILMINGTON, MA – September 28, 2016 – Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO), that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services. The company’s unique […]

Fairmount Partners Assists ICON in their Acquisition of Clinical Research Management, Inc.

Dublin, Ireland – September 19, 2016 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has completed the previously announced acquisition of Clinical Research Management, Inc. (ClinicalRM). The acquisition will enhance ICON’s ability to access the market for government sponsored research and […]

Fairmount Partners Represents Avista Pharma Solutions in Sale of Accuratus Lab Services

DURHAM, NC – September 7, 2016 – Avista Pharma Solutions, Inc. (“Avista Pharma”) has announced the sale of its facility in Eagan, Minn. to Microbiology Research Associates (MRA, Acton, Mass.), a portfolio company of Thompson Street Capital Partners (TSCP). The Eagan facility, which operates as Accuratus Lab Services (Accuratus), is a leading provider of testing […]